AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this episode, Thomas Betts chats with ...

Community driven content discussing all aspects of software development from DevOps to design patterns. This set of AZ-400 practice questions focuses on commonly misunderstood concepts that frequently ...

Community driven content discussing all aspects of software development from DevOps to design patterns. So get ready to test your skills. Good luck on these practice questions, and even better luck ...

If you have non-small-cell lung cancer (NSCLC) with an EGFR mutation, your health care provider may recommend a new medicine called Datroway (datopotamab deruxtecan-dlnk). NSCLC is the most common ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people each year. The test, known as a liquid biopsy, is designed to speed up access ...

This article was produced as part of the New York Jewish Week’s Teen Journalism Fellowship, a program that works with Jewish teens around New York City to report on issues that affect their lives. In ...

Traditional biochemical methods of studying human gene mutations are often laborious and costly. Now bioengineers at the University of California San Diego have developed a new simple approach to ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Google has heated up the app-building space, today rolling out a ...

MONTREAL--(BUSINESS WIRE)--Avitia, an AI company providing end-to-end testing solutions to rapidly identify cancer mutations and applicable treatments, today announced its business launch and $5M seed ...